Bavarian Nordic A/S 2022 AR2
The report highlights Bavarian Nordic's strong financial and operational performance in 2022, driven by the global mpox outbreak which led to significant demand for its JYNNEOS vaccine. The company achieved record-breaking revenue of DKK 3,151 million and a positive EBITDA of DKK 328 million. Key strategic milestones included advancing Phase 3 clinical trials for its RSV and COVID-19 booster vaccine candidates, as well as announcing the acquisition of a travel vaccine portfolio from Emergent BioSolutions. Additionally, the company integrated ESG targets into its remuneration principles and conducted its first climate-related scenario analysis aligned with TCFD recommendations.
Company: Bavarian Nordic A/S
Sector: Manufacturing
Country: Denmark
Year: 2022
Type: AR2
Pages: 142
Back to company
Bavarian Nordic A/S
Annual Report
The report highlights Bavarian Nordic's strong financial and operational performance in 2022, driven by the global mpox outbreak which led to significant demand for its JYNNEOS vaccine. The company achieved record-breaking revenue of DKK 3,151 million and a positive EBITDA of DKK 328 million. Key strategic milestones included advancing Phase 3 clinical trials for its RSV and COVID-19 booster vaccine candidates, as well as announcing the acquisition of a travel vaccine portfolio from Emergent BioSolutions. Additionally, the company integrated ESG targets into its remuneration principles and conducted its first climate-related scenario analysis aligned with TCFD recommendations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Women on Board
Women in Management
Employees